RxDoctor Payments Data

John Mays, MD

Orthopaedic Surgery · Bossier City, LANPI 1689678484

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Heron Therapeutics, Inc. accounts for 81.1% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $18,001 and has fallen 97.7% since, to $414 in 2025.

$39,572in general payments, 2019–2025

Across 194 payments — averaging $203.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Heron Therapeutics, Inc.$32K
  • Midsouth Orthopedics Inc.$2K
  • Zimmer Biomet$1K
  • Stryker$669
  • Johnson & Johnson$666
  • Arthrex$618
  • plus $3K from 26 others

What the payments were for

  • Consulting fees$4,37511%
  • Speaking & faculty fees$21,52554%
  • Travel & lodging$6,15816%
  • Food & beverage$6,16016%
  • Education$1,3543%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,572 in reported general payments places this provider in the 85th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$323,354
Medicare patients
523
Services billed
2,106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib44$2,720
Meloxicam395$1,087
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen113$921
Gabapentin73$702
Duloxetine Hcl55$589
Ondansetron OdtOndansetron93$472
Methylprednisolone73$466
Cefadroxil75$286

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bossier City

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →